Y-Intercept (HK)’s GreenLight Biosciences Holdings, PBC Common Stock GRNA Stock Holding History

Y-Intercept (HK)’s Portfolio GRNA Stock Details GRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-247,816	Closed	-$73.9K	–	1793
2023 Q2	$73.9K	Buy	247,816 +146,996	+146%	+$44.3K	0.01%	1157
2023 Q1	$43.6K	Buy	+100,820	New	+$77.4K	0.01%	1107
2022 Q2	–	Sell	-12,789	Closed	-$123K	–	1279
2022 Q1	$123K	Buy	+12,789	New	+$115K	0.03%	658

Y-Intercept (HK)'s GRNA Position: Q3 2023 in Review

Y-Intercept (HK) sold out of GreenLight Biosciences Holdings, PBC Common Stock (GRNA) in Q3 2023, closing a stake of 247,816 shares — an estimated $73.9K sold.

Y-Intercept (HK) first reported a position in GRNA in Q1 2022 and held it in 3 quarters. The position peaked at $123K in Q1 2022. 0 funds tracked by Wall St. Rank hold GRNA as of Q3 2023.

Y-Intercept (HK) reported no remaining GreenLight Biosciences Holdings, PBC Common Stock position as of Q3 2023 after selling out during the quarter.
Y-Intercept (HK) sold 247,816 GreenLight Biosciences Holdings, PBC Common Stock shares in Q3 2023, an estimated $73.9K.
Y-Intercept (HK) first reported a position in GreenLight Biosciences Holdings, PBC Common Stock in Q1 2022 and held it in 3 quarters.
Y-Intercept (HK)'s GreenLight Biosciences Holdings, PBC Common Stock position peaked at $123K in Q1 2022.
0 funds tracked by Wall St. Rank held GreenLight Biosciences Holdings, PBC Common Stock as of Q3 2023.

Based on Y-Intercept (HK)'s 13F filing for Q3 2023, filed 14 Nov 2023.